Lupus, particularly Systemic Lupus Erythematosus (SLE), is a complex autoimmune condition. It demands a multifaceted approach to both research and treatment. The SLE model, a cornerstone in this domain, is pivotal for understanding the intricacies of lupus and developing effective therapies. In thi Read More

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the production of autoantibodies and widespread inflammation. One of the pivotal components implicated in the pathogenesis of SLE is double-stranded DNA (dsDNA). Understanding the role of dsDNA in SLE model studies i Read More

The Pso (Psoriasis) model is a critical tool in the field of dermatological research, particularly for understanding and developing treatments for Psoriasis. Psoriasis is a chronic autoimmune skin disease characterized by red, itchy, and scaly patches. The Pso model, which includes various animal mo Read More

Understanding MC903 Induced AD Model in DetailAtopic dermatitis (AD) is a chronic inflammatory skin condition characterized by erythematous plaques, eruptions, elevated serum IgE levels, and a T helper cell type 2 (Th2) cytokine profile, including interleukin-4 (IL-4) and interleukin-13 (IL-13). Mic Read More

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that affects multiple organ systems in the body. It is characterized by the production of autoantibodies and the formation of immune complexes, which subsequently lead to inflammation and damage to various tissues. The symptoms of SL Read More

IntroductionAtopic Dermatitis (AD) is a chronic inflammatory skin condition characterized by erythematous plaques, eruptions, and elevated serum IgE levels. It affects millions of people worldwide, causing significant discomfort and impacting the quality of life. The development of effective treatme Read More

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect virtually any organ system, leading to a wide range of symptoms and complications. Understanding this complex disease is a challenge that many researchers have faced over the years. The introduction of animal models i Read More

Client case: Development of a Novel Antibody Drug Targeting IL-25 for Atopic Dermatitis(AD).Client: A pharmaceutical company developing a new antibody targeting the IL-25 pathway for the treatment of ADObjective: To establish the efficacy and safety of the new anti-IL-25 antibody in preclinical mode Read More

Client No.1: Efficacy of Novel Compound in EAE Model Client Background:Our client is a pharmaceutical company that has developed a novel compound designed to target mitochondrial damage-related autophagy and possesses neuroregenerative properties. The client aims to explore the potential therapeutic Read More